AKR1D1 knockout mice develop a sex-dependent metabolic phenotype.


Journal

The Journal of endocrinology
ISSN: 1479-6805
Titre abrégé: J Endocrinol
Pays: England
ID NLM: 0375363

Informations de publication

Date de publication:
13 04 2022
Historique:
received: 11 02 2022
accepted: 23 03 2022
pubmed: 24 3 2022
medline: 15 4 2022
entrez: 23 3 2022
Statut: epublish

Résumé

Steroid 5β-reductase (AKR1D1) plays important role in hepatic bile acid synthesis and glucocorticoid clearance. Bile acids and glucocorticoids are potent metabolic regulators, but whether AKR1D1 controls metabolic phenotype in vivo is unknown. Akr1d1-/- mice were generated on a C57BL/6 background. Liquid chromatography/mass spectrometry, metabolomic and transcriptomic approaches were used to determine effects on glucocorticoid and bile acid homeostasis. Metabolic phenotypes including body weight and composition, lipid homeostasis, glucose tolerance and insulin tolerance were evaluated. Molecular changes were assessed by RNA-Seq and Western blotting. Male Akr1d1-/- mice were challenged with a high fat diet (60% kcal from fat) for 20 weeks. Akr1d1-/- mice had a sex-specific metabolic phenotype. At 30 weeks of age, male, but not female, Akr1d1-/- mice were more insulin tolerant and had reduced lipid accumulation in the liver and adipose tissue yet had hypertriglyceridemia and increased intramuscular triacylglycerol. This phenotype was associated with sexually dimorphic changes in bile acid metabolism and composition but without overt effects on circulating glucocorticoid levels or glucocorticoid-regulated gene expression in the liver. Male Akr1d1-/- mice were not protected against diet-induced obesity and insulin resistance. In conclusion, this study shows that AKR1D1 controls bile acid homeostasis in vivo and that altering its activity can affect insulin tolerance and lipid homeostasis in a sex-dependent manner.

Identifiants

pubmed: 35318963
doi: 10.1530/JOE-21-0280
pii: JOE-21-0280
pmc: PMC9086936
doi:

Substances chimiques

Bile Acids and Salts 0
Glucocorticoids 0
Insulin 0
Lipids 0
Oxidoreductases EC 1.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

97-113

Subventions

Organisme : Medical Research Council
ID : MC_U142661184
Pays : United Kingdom
Organisme : NIEHS NIH HHS
ID : P30 ES013508
Pays : United States
Organisme : Medical Research Council
ID : MR/P011462/1
Pays : United Kingdom

Références

Diabetes. 2015 Apr;64(4):1168-79
pubmed: 25338812
Biochim Biophys Acta. 2011 Aug;1812(8):964-73
pubmed: 21211563
J Clin Endocrinol Metab. 2014 Aug;99(8):E1397-406
pubmed: 24823464
Diabetes. 2013 Dec;62(12):4184-91
pubmed: 23884887
J Steroid Biochem Mol Biol. 2021 Mar;207:105808
pubmed: 33418075
Cells. 2020 Jan 23;9(2):
pubmed: 31979271
Mol Aspects Med. 2017 Aug;56:10-24
pubmed: 28322867
J Hepatol. 2012 Jul;57(1):133-40
pubmed: 22414767
Proc Natl Acad Sci U S A. 2004 May 4;101(18):7088-93
pubmed: 15118095
Steroids. 2014 May;83:17-26
pubmed: 24513054
BMJ. 2019 Apr 10;365:l1204
pubmed: 30971393
Endocrinology. 2015 Jul;156(7):2492-502
pubmed: 25856427
Nat Commun. 2018 Jan 16;9(1):245
pubmed: 29339725
J Endocrinol. 2020 May;245(2):207-218
pubmed: 32106090
Mol Pharmacol. 2006 Oct;70(4):1164-73
pubmed: 16778009
Diabetes. 2007 Jan;56(1):239-47
pubmed: 17192488
J Endocrinol. 2010 Jun;205(3):225-32
pubmed: 20354075
J Biol Chem. 2006 Apr 21;281(16):11039-49
pubmed: 16446356
J Clin Endocrinol Metab. 2003 Oct;88(10):4924-31
pubmed: 14557475
Nat Genet. 2018 Apr;50(4):572-580
pubmed: 29632379
JCI Insight. 2020 Jul 23;5(14):
pubmed: 32699194
Curr Protoc Mouse Biol. 2016 Sep 01;6(3):211-222
pubmed: 27584551
Steroids. 2008 Apr;73(4):417-23
pubmed: 18243262
J Clin Endocrinol Metab. 2000 Feb;85(2):748-54
pubmed: 10690886
J Womens Health Gend Based Med. 2002 Apr;11(3):225-37
pubmed: 11988133
J Steroid Biochem Mol Biol. 2019 May;189:218-227
pubmed: 30769091
Endocr Rev. 2002 Aug;23(4):443-63
pubmed: 12202460
Mol Endocrinol. 2003 Feb;17(2):259-72
pubmed: 12554753
J Biol Chem. 2021 Jan-Jun;296:100131
pubmed: 33262218
Exp Clin Endocrinol Diabetes. 1996;104(2):137-44
pubmed: 8740937
Gastroenterology. 1975 Mar;68(3):534-44
pubmed: 1112455
Trends Mol Med. 2015 Nov;21(11):702-714
pubmed: 26481828
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
J Biol Chem. 2010 Nov 19;285(47):36759-67
pubmed: 20851881
J Lipid Res. 2016 Jul;57(7):1144-54
pubmed: 27146480
J Biol Chem. 2001 Nov 2;276(44):41293-300
pubmed: 11546766
Metabolism. 2019 Oct;99:67-80
pubmed: 31330134
Diabetes. 2015 Feb;64(2):447-58
pubmed: 25239636
Am J Physiol Endocrinol Metab. 2017 Aug 1;313(2):E121-E133
pubmed: 28377401
J Clin Invest. 2004 May;113(10):1408-18
pubmed: 15146238
Gut. 1996 Apr;38(4):623-8
pubmed: 8707100
Steroids. 2008 Oct;73(11):1066-76
pubmed: 18502460
Pharmacogenomics. 2008 Apr;9(4):383-97
pubmed: 18384253
Hepatology. 2017 Mar;65(3):813-827
pubmed: 27351453
Diabetologia. 2021 Jan;64(1):168-180
pubmed: 33128577
Methods Mol Biol. 2019;1951:1-14
pubmed: 30825140
Eur J Clin Invest. 1974 Feb;4(1):59-63
pubmed: 4819836
J Clin Endocrinol Metab. 2016 Jan;101(1):103-13
pubmed: 26574953
Genome Res. 2011 Jun;21(6):936-9
pubmed: 20980556
Lancet. 2006 May 13;367(9522):1605-17
pubmed: 16698415
Mol Cell Endocrinol. 2018 Jul 15;470:127-141
pubmed: 29024782
Endocrinology. 2013 Dec;154(12):4536-47
pubmed: 24080367

Auteurs

Laura L Gathercole (LL)

Oxford Centre for Diabetes, Endocrinology and Metabolism, NIHR Oxford Biomedical Research Centre, University of Oxford, Churchill Hospital, Oxford, UK.
Department of Biological and Medical Sciences, Oxford Brookes University, Oxford, UK.

Nikolaos Nikolaou (N)

Oxford Centre for Diabetes, Endocrinology and Metabolism, NIHR Oxford Biomedical Research Centre, University of Oxford, Churchill Hospital, Oxford, UK.

Shelley E Harris (SE)

Oxford Centre for Diabetes, Endocrinology and Metabolism, NIHR Oxford Biomedical Research Centre, University of Oxford, Churchill Hospital, Oxford, UK.

Anastasia Arvaniti (A)

Oxford Centre for Diabetes, Endocrinology and Metabolism, NIHR Oxford Biomedical Research Centre, University of Oxford, Churchill Hospital, Oxford, UK.
Department of Biological and Medical Sciences, Oxford Brookes University, Oxford, UK.

Toryn M Poolman (TM)

Oxford Centre for Diabetes, Endocrinology and Metabolism, NIHR Oxford Biomedical Research Centre, University of Oxford, Churchill Hospital, Oxford, UK.

Jonathan M Hazlehurst (JM)

Oxford Centre for Diabetes, Endocrinology and Metabolism, NIHR Oxford Biomedical Research Centre, University of Oxford, Churchill Hospital, Oxford, UK.
Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, UK.

Denise V Kratschmar (DV)

Swiss Centre for Applied Human Toxicology and Division of Molecular and Systems Toxicology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.

Marijana Todorčević (M)

Oxford Centre for Diabetes, Endocrinology and Metabolism, NIHR Oxford Biomedical Research Centre, University of Oxford, Churchill Hospital, Oxford, UK.

Ahmad Moolla (A)

Oxford Centre for Diabetes, Endocrinology and Metabolism, NIHR Oxford Biomedical Research Centre, University of Oxford, Churchill Hospital, Oxford, UK.

Niall Dempster (N)

Oxford Centre for Diabetes, Endocrinology and Metabolism, NIHR Oxford Biomedical Research Centre, University of Oxford, Churchill Hospital, Oxford, UK.

Ryan C Pink (RC)

Department of Biological and Medical Sciences, Oxford Brookes University, Oxford, UK.

Michael F Saikali (MF)

Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada.

Liz Bentley (L)

Mammalian Genetics Unit, Medical Research Council Harwell, Oxford, UK.

Trevor M Penning (TM)

Center of Excellence in Environmental Toxicology, Department of Systems Pharmacology & Translational Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

Claes Ohlsson (C)

Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Carolyn L Cummins (CL)

Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada.

Matti Poutanen (M)

Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Institute of Biomedicine, Research Centre for Integrative Physiology and Pharmacology, University of Turku, Turku, Finland.

Alex Odermatt (A)

Swiss Centre for Applied Human Toxicology and Division of Molecular and Systems Toxicology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.

Roger D Cox (RD)

Mammalian Genetics Unit, Medical Research Council Harwell, Oxford, UK.

Jeremy W Tomlinson (JW)

Oxford Centre for Diabetes, Endocrinology and Metabolism, NIHR Oxford Biomedical Research Centre, University of Oxford, Churchill Hospital, Oxford, UK.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH